Strong medicine for Perry in China

Mon Mar 3, 2008



By Pete Gallo

No, it hasn't been a promising season for investors in medical stocks. That is unless you are talking about Perry Capital and its growing portfolio of med stocks in the Far East. Mind you, Perry isn't just dabbling in the sector. In some instances, it's a dominant player. Filings with the Securities and Exchange Commission show that as of early February, Perry was the largest investor in China Medical Technologies, a stock that has exploded in value over the past year.

Perry holds roughly a 12% stake in China Medical, some 3.3 million shares, based on February 14 filings with the SEC. That's good news for Perry, as the stock has jumped from $21 a share to $54 over the past six months. About $10 of that gain came in January and early February, increasing Perry's stake to $178.2 million - a profit of...

ISSN: 2151-1845 / CDC10004H

TAKE A FREE TRIAL

The full contents of this article are available to active AR subscribers and trialists only.

To continue reading please,
take a free trialsubscribe or log in to AR.

Subscribe

Subscribers have unlimited access to all current and archive content. Start your subscription today - click on the button below.

Subscribe now